Competition in the OTC drug and nutritional product arenas rarely slows, and "The Tan Sheet" knows businesses around the world vigilantly maintain their conditioning to be ready to run, jump or defend as occasion demands. We note some news items this week that point specifically to firms striving ever onward despite hurdles or obstacles in their course.
Closure on Johnson & Johnson’s year of OTC recalls remains elusive: "The Tan Sheet" reports...
Price not a factor as Piramal looks to add OTC businesses: livemint.com says...
Opurity vitamin maker stays "China Free" course without trademark: ProSynthesis Labs says...
Arbitration panel says accidental DHEA use caused sprinter's positive tests: The Washington Post reports...
(Every week, "The Tan Sheet" reaches the finish line first with the latest developments affecting OTC drugs and nutritionals. Get your free trial subscription started by clicking here.)
Continue reading "OTC And Nutritional News Roundup: In It To Win It Edition" »


